CMOC Group Limited (03993) plans to invest 500 million yuan in participating in a private equity investment fund focused on three promising industries: technology, healthcare, consumer goods, and retail.

date
22:31 02/12/2025
avatar
GMT Eight
Luoyang Molybdenum Industry (03993) announced that the company's wholly-owned subsidiary, Tibet Shimok (as a limited partner), Boyu Tianshu (as a general partner), and Boyu New Intelligent New Production (Ningbo) Equity Investment Partnership Enterprise (limited partner) (the Fund) and other limited partners have entered into a partnership agreement. According to this agreement, the contracting parties agree to invest in the Fund, with Tibet Shimok agreeing to invest 500 million yuan in the Fund. The target size of the Fund is 8-10 billion yuan, focusing mainly on the three sunrise industries of technology, medical health, consumer goods, and retail.
CMOC Group Limited (03993) announced that its wholly-owned subsidiaries, Tibet Shemoke (as limited partner), Boyu Tianyu (as general partner), and Boyu Xin Zhi Xin Chan (Ningbo) Equity Investment Partnership Enterprise (limited partnership) (the Fund) have entered into a partnership agreement with other limited partners. According to this agreement, the contracting parties agree to invest in the Fund, with Tibet Shemoke agreeing to invest 500 million yuan in the Fund. The target size of the Fund is 8-10 billion yuan, focusing mainly on the three sunrise industries of technology, medical health, and consumer goods and retail. The company will implement this investment while ensuring the daily operation and financial security, and it will not affect the company's normal turnover of funds. The purpose of this investment is to leverage the advantages of professional investment institutions to improve investment returns and create reasonable investment returns for the company and shareholders. The funds for this investment come from the company's own funds and will not have a significant impact on the company's financial condition or operational results, nor will it harm the interests of the company and shareholders.